Abstract:Purpose: Overexpression of extracellular matrix metalloproteinase inducer (EMMPRIN), a member of the immunoglobulin family and a glycoprotein enriched on the surface of many types of tumor cells, has been reported to be linked to invasion, metastasis, growth, and survival of malignant cells. Cervical cancer, the second most prevalent cancer in women worldwide and the fifth leading cause of cancer deaths, responds to radiotherapy variably, with 30% of cases recurring after therapy. The purpose of this study was to determine whether expression of EMMPRIN affects the response of cervical cancer to radiation therapy, and whether this membrane protein can be used as a prognostic marker for cervical cancer.Experimental Design: The retrospective cohort study included 82 patients with invasive cervical cancer referred to the Department of Gynecologic Oncology at The Cancer Hospital of Fudan University (Shanghai) between 1991 and 2000. These patients were treated with brachytherapy at a dose of 15 Gy at point A before radical hysterectomy. Expression of EMMPRIN in cervical tumor specimens was examined by immunohistochemistry staining before and after brachytherapy and scored for both staining intensity and percentage of tumor cells stained. EMMPRIN immunoreactivity and clinicopathologic data were analyzed with respect to survival end points using univariate and multivariate approaches.Results: The frequency of EMMPRIN overexpression was 52.4% in primary cervical cancer. After brachytherapy, EMMPRIN overexpression was significantly reduced (13.4%) compared with corresponding tumor before brachytherapy (P = 0.032). EMMPRIN expression was associated with pelvic lymph node metastasis (P = 0.026) and reduction in primary tumor volume following brachytherapy (P = 0.008). Although EMMPRIN expression before or after brachytherapy did not correlate with tumor-specific survival, but increased expression of EMMPRIN following brachytherapy tended to predict poor outcomes by univariate survival analysis (P = 0.0008). In addition, lymph vascular space invasion, deep stromal invasion, and lymph node metastasis were significantly associated with poor prognosis. In multivariate analysis, the independent prognostic factors for tumor-specific survival included the decreased expression of EMMPRIN after brachytherapy (P = 0.002; hazard ratio, 0.339; 95% confidence interval, 0.172-0.672) as well as lymph node metastasis (P = 0.044; hazard ratio, 2.053; 95% confidence interval, 1.020-4.133).Conclusion: Expression of EMMPRIN was associated with a decrease in the reduction of cervical tumor following brachytherapy, and increased EMMPRIN expression after brachytherapy seemed to be an important predictor of poor survival in this patient cohort. Our study suggests that expression of EMMPRIN confers resistance to radiotherapy. Therefore, EMMPRIN expression in cervical cancer may be regarded both as a prognostic factor and a therapeutic target.

Expression of extracellular matrix metalloproteinase inducer in tongue squamous cell carcinoma and correlation with prognosis

EMMPRIN Expression in Tongue Squamous Cell Carcinoma.

[Expression of Extracellular Matrix Metalloproteinase Inducer in Laryngeal Squamous Cell Carcinoma].

Extracellular Matrix Metalloproteinase Inducer Expression in Salivary Gland Tumors: a Correlation with Microvessel Density.

Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer

Evaluation of EMMPRIN (CD147) Expression in Cervical Cancer: a Critical Role in Development and Progression

EMMPRIN Expression As a Prognostic Factor in Radiotherapy of Cervical Cancer

[Expression of Notch1 and Epidermal Growth Factor Receptor in Human Tongue Squamous Cell Carcinoma and Precancerous Lesion].

Significance of expression of extracellular matrix metalloproteinase inducer in pancreatic cancer

Neutrophils Infiltration in the Tongue Squamous Cell Carcinoma and Its Correlation with CEACAM1 Expression on Tumor Cells

The Clinicopathological Significance and Prognostic Value of EMMPRIN Overexpression in Cancers: Evidence from 39 Cohort Studies.

Prognostic Significance of Erythropoietin and Erythropoietin Receptor in Tongue Squamous Cell Carcinoma

Immunoexpression of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in the Metastasis of Squamous Cell Carcinoma of the Human Tongue

Significance of Epithelial-Mesenchymal Transition and Its Relation with Vasculogenic Mimicry in Human Tongue Squamous Cell Carcinoma

Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis

The Significance of the Expression of Extracellular Matrix Metalloproteinase Inducer in Colorectal Cancer by Western Blot

Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.

Expression of EphA2 and VEGF in Squamous Cell Carcinoma of the Tongue: Correlation with the Angiogenesis and Clinical Outcome

Corrlations of EMMPRIN and MMP-2 expressions with clinicopathological features in colon cancer

Expression and Clinical Significance of Motility-Related Protein(mrp-1/Cd9) and MMP-2 in Squamous Cell Carcinoma of the Tongue

Study on Relationships Between Expressions of Matrix Regulated Proteins and Count of Mast Cell in Pancreatic Cancer Tissues